Pharma Sector Weight in Sensex to Hit an 8-year Low: Motilal Oswal
The weightage of healthcare in the S&P BSE Sensex will be at an eight-year low with the exclusion of Dr. Reddy’s Laboratories, said Motilal Oswal Securities in a report. The S&P BSE Sensex has been reshuffled with Vedanta will be replacing Dr. Reddy’s Labs.
The drop in weightage is also due to the significant under-performance of the sector over the last two years. Sun Pharma (weight: 1.7%) will be the only healthcare stock in the benchmark index.
Over the years, the sectoral representation in the Sensex has undergone a sea change in consonance with the changes in the underlying economy – new sectors have evolved, while some of the erstwhile dominant sectors have lost relative importance in the new India, said the report.
2026-10-22
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
24th Pharma Asia Kicks Off in Karachi, Pakistan’s Largest Pharmaceutical Industry Event
-
24th Pharma Asia International Exhibition & Conferences to Open in Karachi, Pakistan
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
CPHI & PMEC India 2026
-
8th Annual Pharma Manufacturing and Automation Convention 2026
-
Pharma Manufacturing & Automation Excellence Awards 2026
-
CPHI Korea 2026: A Leading Gateway to Korea’s Pharmaceutical and Biopharma Market
-
Pharmaconex
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
Recommend Reading
-
Trump Tariff "Boomerang": $2.5 Billion Polysilicon Factory Faces Shutdown Crisis
-
U.S. Strikes Three Iranian Tankers as “Tanker-for-Tanker” Escalation Raises Chemical Shipping Risk
-
Panama Canal Delays Deeper Draft Cut, but Transit Capacity Is Still Tightening
-
Shandong’s Export Growth Is 2.8%; This Category Is 19%: Shandong Has a Chokehold on the Upstream of Global Manufacturing
-
Global Trade Data for Epoxy Resin in 2025 Released: Asia Accounted for $640 Million in Imports, Vietnam Emerges as Top Buyer
-
Business Society October 10, 2026 Hydrogen Peroxide Trend Analysis: Volatility
-
Business Society October 10, 2026 ABS Market Outlook: Clear Uptrend
-
September Favorable Factors Drive Shandong Cyclohexanone Market to Rise
-
Business Society’s Market Outlook for Epichlorohydrin on September 7, 2026: Fluctuating (Bullish) Trend
-
Cost Easing and Weakening Year-End Demand Leave Acrylic Market Stuck in a Standoff